Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

FIGS Releases Fourth Quarter and Full Year 2022 Financial Results

2022 Net Revenues Growth of 20.6% YoY, Net Income of $21.2 million, Net Income Margin of 4.2% and Adjusted EBITDA Margin of 17.2%

FIGS, Inc. (NYSE: FIGS) (the “Company”), the direct-to-consumer apparel and lifestyle brand dedicated to the healthcare community, today released its fourth quarter and full year 2022 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.

Fourth Quarter 2022 Financial Highlights

  • Net revenues were $144.9 million, an increase of 12.6% year over year, driven by an increase in orders from existing and new customers, partially offset by a slightly lower average order value (“AOV”) from $113 to $112.
  • Gross margin was 68.2%, a decrease of 170 basis points year over year, primarily due to a higher mix of promotional sales and product mix shift as well as higher ocean freight costs, partially offset by reduced utilization of air freight.
  • Operating expenses were $95.6 million, an increase of 29.9% year over year. As a percentage of net revenues, operating expenses increased to 66.0% from 57.2% in the prior year due to higher selling expenses related to fulfillment costs.
  • Net income was $3.4 million and diluted earnings per share was $0.02.
  • Net income margin(1) was 2.3%, as compared to 9.8% in the same period last year.
  • Net income, as adjusted(2) was $8.2 million and diluted earnings per share, as adjusted(1) was $0.05.
  • Adjusted EBITDA(2) was $19.8 million or 13.6% of net revenues, as compared to $31.9 million or 24.8% of net revenues in the same period last year.

“We delivered fourth quarter results ahead of our expectations reflecting strong holiday performance as well as growth in our non scrubwear and international businesses.” said Trina Spear, Chief Executive Officer and Co-Founder. “Our priorities for 2023 will be positioning our Company for long term growth while maintaining sustainable, profitable margins as we manage through an uncertain macro environment. We remain confident in our long term outlook as a result of our industry leading product innovation, community connection and advocacy. We believe we have the scale and balance sheet to take our business to the next level, making strategic, disciplined investments in our future as we aim to double our annual net revenues to $1 billion.”

Full Year 2022 Financial Highlights

  • Net revenues were $505.8 million, an increase of 20.6% year over year, primarily driven by an increase in orders and AOV.
  • Gross margin was 70.1%, a decrease of 170 basis points year over year, primarily due to a higher mix of promotional sales and, to a lesser extent, an increase in freight-in due to elevated ocean freight rates and product mix shift.
  • Operating expenses were $316.8 million, an increase of 9.1% year over year. As a percentage of net revenues, operating expenses decreased to 62.6% from 69.2% in the prior year period due to lower general and administrative expenses, partially offset by higher selling expense and marketing investment.
  • Net income was $21.2 million and diluted earnings per share was $0.11.
  • Net income margin(1) was 4.2%, as compared to (2.3)% in the same period last year.
  • Net income, as adjusted(2) was $29.2 million and diluted earnings per share, as adjusted(1) was $0.16.
  • Adjusted EBITDA(2) was $87.3 million or 17.2% of net revenues, as compared to $105.2 million or 25.1% of net revenue in the same period last year.

Full Year 2022 Key Operating Metrics

  • Active customers(3) as of December 31, 2022 increased 22.5% year over year to 2.3 million.
  • Net revenues per active customer(3) was $221, a decrease of 1.3% year over year.
  • AOV(3) was $112, an increase of 6.7% year over year primarily driven by higher units per transaction as well as an increase in average unit retail.

2023 Financial Outlook

Net Revenues

Mid-single digit growth

 

 

Adjusted EBITDA Margin(4)

11% - 12%

Daniella Turenshine, Chief Financial Officer, commented, “Our growth outlook for 2023 is not representative of the growth we believe we can achieve long term. That is why we plan to keep investing while managing our business prudently through near term macro and cost challenges. We remain a distant leader in our industry and we are confident that we can accelerate growth and deliver adjusted EBITDA margin expansion in the future.”

(1)

 

“Net income margin” and “adjusted EBITDA margin” are calculated by dividing net income and adjusted EBITDA by net revenues, respectively.

(2)

 

“Net income, as adjusted,” “diluted earnings per share, as adjusted,” “adjusted EBITDA” and “adjusted EBITDA margin” are non-GAAP financial measures. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Reconciliations of GAAP to Non-GAAP Measures” below for more information regarding the Company’s use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.

(3)

 

“Active customers,” “net revenues per active customer” and “average order value” are key operational and business metrics that are important to understanding the Company’s performance. For information regarding how the Company calculates its key operational and business metrics, please see the section titled “Non-GAAP Financial Measures and Key Operating Metrics.”

(4)

 

The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income margin outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company’s control or ability to predict. For more information regarding the Company’s use of non-GAAP financial measures, please see the section titled “Non-GAAP Financial Measures and Key Operating Metrics.”

Conference Call Details

FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company’s financial and business results and outlook. To participate, please dial 1-844-200-6205 (US) or 1-929-526-1599 (International) and the conference ID 164244. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call until 11:59 p.m. ET on March 7, 2023. To access the replay, please dial 1-866-813-9403 (US) or +44-204-525-0658 (International) and the conference ID 579986. An archive of the webcast will be available on FIGS’ investor relations website at ir.wearfigs.com.

Non-GAAP Financial Measures and Key Operating Metrics

In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company has also included “active customers,” “net revenues per active customer” and “average order value,” which are key operational and business metrics that are important to understanding Company performance. The Company calculates “active customers” as unique customer accounts that have made at least one purchase in the preceding 12-month period. The Company calculates “net revenues per active customer” as the sum of the total net revenues in the preceding 12-month period divided by the current period “active customers.” The Company calculates “average order value” as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period.

The Company uses “net income, as adjusted,” “diluted earnings per share, as adjusted,” “adjusted EBITDA” and “adjusted EBITDA margin” to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company calculates “net income, as adjusted,” as net income adjusted to exclude transaction costs, expenses related to non-ordinary course disputes, other than temporary impairment of held-to-maturity investments, stock-based compensation, including expense related to award modifications, accelerated performance awards and ambassador grants in connection with its initial public offering, and expense resulting from the retirement of the Company’s previous CFO, and the income tax impact of these adjustments. The Company calculates “diluted earnings per share, as adjusted” as net income, as adjusted divided by diluted shares outstanding. The Company calculates “adjusted EBITDA” as net income adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates “adjusted EBITDA margin” by dividing adjusted EBITDA by net revenues.

Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading “Reconciliations of GAAP to Non-GAAP Measures.”

About FIGS

FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products for healthcare professionals that feature an unmatched combination of comfort, durability, function, and style. We market and sell our products in 14 countries directly through our digital platform to provide a seamless experience for healthcare professionals.

Forward Looking Statements

This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words “anticipate”, “believe”, “contemplate”, “continue”, “could”, “estimate”, “expect”, “forecast”, “future”, “intend”, “may”, “might”, “opportunity”, “outlook”, “plan”, “possible”, “potential”, “predict”, “project,” “should”, “strategy”, “strive”, “target”, “will” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company’s priorities for 2023, including positioning the Company for long term growth while maintaining sustainable, profitable margins as it manages through an uncertain macro environment; the Company’s long term outlook and future growth potential; the Company’s industry leading product innovation, community connection and advocacy; the Company’s belief that it has the scale and balance sheet to advance its business; the Company’s expectation to make strategic, disciplined investments in its future; the Company’s aim to achieve annual net revenues of $1 billion; the Company’s plan to invest while managing its business prudently through near term macro and cost challenges; the Company’s positioning in its industry; the Company’s belief it can accelerate growth and deliver adjusted EBITDA margin expansion in the future; and the Company’s outlook as to net revenues and adjusted EBITDA margin for the full year ending December 31, 2023; all of which reflect the Company’s expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, our actual results performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the impact of COVID-19 and macroeconomic trends on the Company’s operations; the Company’s ability to maintain its recent rapid growth; the Company’s ability to maintain profitability; the Company’s ability to maintain the value and reputation of its brand; the Company’s ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company’s marketing efforts; the Company’s ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company’s marketing efforts or use of social media; the Company’s ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company’s ability to maintain its key employees; the Company’s ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company’s shipping arrangements; the successful operation of the Company’s distribution and warehouse management systems; the Company’s ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company’s products; the Company’s reliance on a limited number of third-party suppliers; the fluctuating costs of raw materials; the Company’s failure to protect its intellectual property rights; the fact that the operations of many of the Company’s suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties, and factors discussed in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2022 to be filed with the SEC, and our other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.

 

FIGS, INC.

BALANCE SHEETS

(In thousands, except share and per share data)

 

 

 

As of

 

December 31,

2022

 

December 31,

2021

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

159,775

 

$

195,374

Restricted cash

 

 

 

2,056

Accounts receivable

 

6,866

 

 

2,441

Inventory, net

 

177,976

 

 

86,068

Prepaid expenses and other current assets

 

11,883

 

 

7,400

Total current assets

 

356,500

 

 

293,339

Non-current assets

 

 

 

Property and equipment, net

 

11,024

 

 

7,613

Operating lease right-of-use assets

 

15,312

 

 

Deferred tax assets

 

10,971

 

 

10,239

Other assets

 

1,257

 

 

560

Total non-current assets

 

38,564

 

 

18,412

Total assets

$

395,064

 

$

311,751

Liabilities and stockholders’ equity

 

 

 

Current liabilities

 

 

 

Accounts payable

$

20,906

 

$

14,604

Operating lease liabilities

 

3,408

 

 

Accrued expenses

 

26,164

 

 

24,677

Accrued compensation and benefits

 

3,415

 

 

6,464

Sales tax payable

 

3,374

 

 

3,728

Gift card liability

 

7,882

 

 

5,590

Deferred revenue

 

2,786

 

 

596

Returns reserve

 

3,458

 

 

2,761

Income tax payable

 

 

 

3,973

Total current liabilities

 

71,393

 

 

62,393

Non-current liabilities

 

 

 

Operating lease liabilities, non-current

 

15,756

 

 

Deferred rent and lease incentive

 

 

 

3,542

Other non-current liabilities

 

176

 

 

243

Total liabilities

 

87,325

 

 

66,178

Commitments and contingencies

 

 

 

Stockholders’ equity

 

 

 

Class A common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of December 31, 2022 and December 31, 2021; 159,351,307 and 152,098,257 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively

 

16

 

 

15

Class B common stock — par value $0.0001 per share, 150,000,000 shares authorized as of December 31, 2022 and December 31, 2021; 7,210,795 and 12,158,187 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively

 

 

 

1

Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of December 31, 2022 and December 31, 2021; zero shares issued and outstanding as of December 31, 2022 and December 31, 2021

 

 

 

Additional paid-in capital

 

268,606

 

 

227,626

Retained earnings

 

39,117

 

 

17,931

Total stockholders’ equity

 

307,739

 

 

245,573

Total liabilities and stockholders’ equity

$

395,064

 

$

311,751

 

FIGS, INC.

STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

 

 

Three months ended December 31,

 

Year ended December 31,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

(unaudited)

 

 

 

 

Net revenues

$

144,898

 

 

$

128,699

 

 

$

505,835

 

 

$

419,591

 

Cost of goods sold

 

46,050

 

 

 

38,696

 

 

 

151,375

 

 

 

118,370

 

Gross profit

 

98,848

 

 

 

90,003

 

 

 

354,460

 

 

 

301,221

 

Operating expenses

 

 

 

 

 

 

 

Selling

 

37,649

 

 

 

25,641

 

 

 

118,449

 

 

 

81,923

 

Marketing

 

21,428

 

 

 

16,606

 

 

 

77,692

 

 

 

58,713

 

General and administrative

 

36,511

 

 

 

31,322

 

 

 

120,653

 

 

 

149,602

 

Total operating expenses

 

95,588

 

 

 

73,569

 

 

 

316,794

 

 

 

290,238

 

Net income from operations

 

3,260

 

 

 

16,434

 

 

 

37,666

 

 

 

10,983

 

Other income (loss), net

 

 

 

 

 

 

 

Interest income (expense)

 

880

 

 

 

(63

)

 

 

1,708

 

 

 

(239

)

Other expense

 

(502

)

 

 

(60

)

 

 

(647

)

 

 

(885

)

Total other income (loss), net

 

378

 

 

 

(123

)

 

 

1,061

 

 

 

(1,124

)

Net income before provision for income taxes

 

3,638

 

 

 

16,311

 

 

 

38,727

 

 

 

9,859

 

Provision for income taxes

 

247

 

 

 

3,715

 

 

 

17,541

 

 

 

19,415

 

Net income (loss) and comprehensive income (loss)

$

3,391

 

 

$

12,596

 

 

$

21,186

 

 

$

(9,556

)

Earnings (loss) attributable to Class A and Class B common stockholders

 

 

 

 

 

 

 

Basic earnings (loss) per share

$

0.02

 

 

$

0.08

 

 

$

0.13

 

 

$

(0.06

)

Diluted earnings (loss) per share

$

0.02

 

 

$

0.06

 

 

$

0.11

 

 

$

(0.06

)

Weighted-average shares outstanding—basic

 

166,181,027

 

 

 

163,798,354

 

 

 

165,268,185

 

 

 

159,177,713

 

Weighted-average shares outstanding—diluted

 

180,892,774

 

 

 

197,977,552

 

 

 

187,547,474

 

 

 

159,177,713

 

 

FIGS, INC.

STATEMENTS OF CASH FLOWS

(In thousands)

 

 

Year ended

December 31,

 

 

2022

 

 

 

2021

 

 

Cash flows from operating activities:

 

 

 

 

Net income (loss)

$

21,186

 

 

$

(9,556

)

 

Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:

 

 

 

 

Depreciation and amortization expense

 

1,924

 

 

 

1,424

 

 

Deferred income taxes

 

(732

)

 

 

(3,732

)

 

Non-cash operating lease cost

 

2,381

 

 

 

 

 

Stock-based compensation

 

37,458

 

 

 

81,139

 

 

Changes in operating assets and liabilities:

 

 

 

 

Accounts receivable

 

(4,425

)

 

 

3,339

 

 

Inventory

 

(91,908

)

 

 

(36,333

)

 

Prepaid expenses and other current assets

 

(4,483

)

 

 

(735

)

 

Other assets

 

(197

)

 

 

127

 

 

Accounts payable

 

6,315

 

 

 

2,855

 

 

Accrued expenses

 

1,487

 

 

 

17,983

 

 

Deferred revenue

 

2,190

 

 

 

(1,185

)

 

Accrued compensation and benefits

 

(3,049

)

 

 

2,250

 

 

Returns reserve

 

697

 

 

 

1,084

 

 

Sales tax payable

 

(354

)

 

 

652

 

 

Income tax payable

 

(3,973

)

 

 

4,428

 

 

Gift card liability

 

2,292

 

 

 

2,571

 

 

Deferred rent and lease incentive

 

 

 

 

(117

)

 

Operating lease liabilities

 

(2,071

)

 

 

 

 

Other non-current liabilities

 

(67

)

 

 

243

 

 

Net cash (used in) provided by operating activities

 

(35,329

)

 

 

66,437

 

 

Cash flows from investing activities:

 

 

 

 

Purchases of property and equipment

 

(5,348

)

 

 

(2,712

)

 

Purchases of held-to-maturity securities

 

(500

)

 

 

 

 

Net cash used in investing activities

 

(5,848

)

 

 

(2,712

)

 

Cash flows from financing activities:

 

 

 

 

Proceeds from issuance of Class A common stock in initial public offering, net of underwriting discounts

 

 

 

 

95,881

 

 

Payments of initial public offering issuance costs, net of reimbursements

 

 

 

 

(780

)

 

Payment of debt issuance and financing costs

 

 

 

 

(181

)

 

Proceeds from capital contributions

 

479

 

 

 

1,301

 

 

Proceeds from stock option exercises and employee stock purchases

 

3,043

 

 

 

907

 

 

Tax payments related to net share settlements on restricted stock units

 

 

 

 

(21,556

)

 

Net cash provided by financing activities

 

3,522

 

 

 

75,572

 

 

Net (decrease) increase in cash, cash equivalents, and restricted cash

 

(37,655

)

 

 

139,297

 

 

Cash, cash equivalents, and restricted cash, beginning of period

$

197,430

 

 

$

58,133

 

 

Cash, cash equivalents, and restricted cash, end of period

$

159,775

 

 

$

197,430

 

 

Supplemental disclosures:

 

 

 

 

Cash paid for income taxes, net of refunds received

$

11,903

 

 

$

15,004

 

 

Property and equipment included in accounts payable and accrued expenses

$

19

 

 

$

32

 

 

Deferred offering costs recorded in stockholders’ equity upon initial public offering, net of related tax impacts

$

 

 

$

220

 

 

FIGS, INC.

RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES

(Unaudited)

The following table presents a reconciliation of Net income, as adjusted and Diluted earnings per share, as adjusted to Net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP:

 

Three Months Ended

December 31,

 

 

Year Ended

December 31,

 

 

2022

 

 

 

2021

 

 

 

 

2022

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

(in thousands, except share and per share data)

Net income (loss)

$

3,391

 

 

$

12,596

 

 

 

$

21,186

 

 

$

(9,556

)

Add (deduct):

 

 

 

 

 

 

 

 

Transaction costs

 

 

 

 

59

 

 

 

 

145

 

 

 

2,019

 

Expenses related to non-ordinary course disputes(1)

 

4,671

 

 

 

1,976

 

 

 

 

10,128

 

 

 

8,183

 

Stock-based compensation expense in connection with the IPO and other(2)

 

 

 

 

5,700

 

 

 

 

 

 

 

56,084

 

Other(3)

 

500

 

 

 

 

 

 

 

500

 

 

 

 

Income tax impacts of items above

 

(350

)

 

 

(1,761

)

 

 

 

(2,808

)

 

 

(843

)

Net income, as adjusted

$

8,212

 

 

$

18,570

 

 

 

$

29,151

 

 

$

55,887

 

Diluted EPS, as adjusted

$

0.05

 

 

$

0.09

 

 

 

$

0.16

 

 

$

0.30

 

Weighted-average shares used to compute Diluted EPS, as adjusted(4)

 

180,892,774

 

 

 

197,977,552

 

 

 

 

187,547,474

 

 

 

189,082,110

 

(1)

 

Represents certain legal fees incurred in connection with the litigation claims described in the section titled “Legal Proceedings” appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

(2)

 

Includes certain stock-based compensation expenses including expense related to award modifications, accelerated performance awards and ambassador grants in connection with the IPO, and expense resulting from the retirement of the Company’s previous CFO.

(3)

 

Includes other than temporary impairment of held-to-maturity investments.

(4)

 

We adjust the weighted-average number of shares outstanding for the dilutive effect of potential common equivalent shares in each period presented.

The following table presents a reconciliation of Adjusted EBITDA to Net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP, and presents Adjusted EBITDA margin with Net income (loss) margin, which is the most directly comparable financial measure calculated in accordance with GAAP:

 

Three Months Ended

December 31,

 

 

Year Ended

December 31,

 

 

2022

 

 

 

2021

 

 

 

 

2022

 

 

 

2021

 

 

(in thousands, except margin)

Net income (loss)

$

3,391

 

 

$

12,596

 

 

 

$

21,186

 

 

$

(9,556

)

Add (deduct):

 

 

 

 

 

 

 

 

Other income (loss), net

 

(378

)

 

 

122

 

 

 

 

(1,061

)

 

 

1,124

 

Provision for income taxes

 

246

 

 

 

3,715

 

 

 

 

17,541

 

 

 

19,415

 

Depreciation and amortization expense(1)

 

638

 

 

 

403

 

 

 

 

1,924

 

 

 

1,424

 

Stock-based compensation and related expense(2)

 

11,197

 

 

 

13,101

 

 

 

 

37,533

 

 

 

83,516

 

Transaction costs

 

 

 

 

 

 

 

 

 

 

 

1,139

 

Expenses related to non-ordinary course disputes(3)

 

4,671

 

 

 

1,976

 

 

 

 

10,128

 

 

 

8,183

 

Adjusted EBITDA

$

19,765

 

 

$

31,913

 

 

 

$

87,251

 

 

$

105,245

 

 

 

 

 

 

 

 

 

 

Net Revenue

$

144,898

 

 

$

128,699

 

 

 

$

505,835

 

 

$

419,591

 

Net income (loss) margin(4)

 

2.3

%

 

 

9.8

%

 

 

 

4.2

%

 

 

(2.3

)%

Adjusted EBITDA Margin

 

13.6

%

 

 

24.8

%

 

 

 

17.2

%

 

 

25.1

%

(1)

 

Excludes amortization of debt issuance costs included in “Other income (loss), net.”

(2)

 

Includes stock-based compensation expense and payroll taxes related to equity award activity.

(3)

 

Represents legal fees incurred in connection with certain of the litigation claims described in the section titled “Legal Proceedings” appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

(4)

 

Net income (loss) margin represents Net income (loss) as a percentage of Net revenues.

FIGS, INC.

KEY OPERATING METRICS

(Unaudited)

Active customers as of December 31, 2022 and 2021, respectively, net revenues per active customer as of December 31, 2022 and 2021, respectively, and average order value for the year ended December 31, 2022 and 2021, respectively, are presented in the following tables:

 

As of December 31,

 

2022

 

2021

 

(in thousands)

Active customers

2,294

 

1,872

 

As of December 31,

 

 

2022

 

 

2021

Net revenues per active customer

$

221

 

$

224

 

Year ended

December 31,

 

 

2022

 

 

2021

Average order value

$

112

 

$

105

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.